2-substituted 5,6-diaryl-pyrazine derivatives as CB1 modulators

Details for Australian Patent Application No. 2004247615 (hide)

Owner AstraZeneca AB

Inventors Berggren, Kristina; Cheng, Leifeng; Sorensen, Henrik; Elebring, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2004247615

PCT Pub. Number WO2004/111033

Priority 0314061.3 18.06.03 GB; 0314059.7 18.06.03 GB

Filing date 16 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 21 February 2008

International Classifications

C07D 241/24 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/497 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/111033 Priority application(s): WO2004/111033

19 April 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read 2-substituted 5, 6-diaryl-pyrazine derivatives as CB1 modulator.

21 February 2008 Application Accepted

  Published as AU-B-2004247615

19 June 2008 Standard Patent Sealed

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247616-3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as CB1 modulators

2004247614-2,3-substituted 5,6-diaryl-pyrazine derivatives as CB1 modulators